XML 34 R22.htm IDEA: XBRL DOCUMENT
v3.19.2

Stock Based Compensation (Notes) | 6 Months Ended
--- | ---
Jun. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock Based Compensation | Stock-Based Compensation Our Board of Directors granted 207,000 stock options, 6,945 deferred stock units and 233,619 restricted stock units during the six months ended June 30, 2019 under our Omnibus Equity Incentive Plan. In the three months ended June 30, 2019 and 2018, we recognized $0.6 million and $0.2 million, respectively, in stock-based compensation expense. A majority of the expense, $0.5 million and $0.2 million respectively, was recorded as selling and administrative expenses in the Consolidated Statement of Operations, with the remaining expenses incurred as cost of sales and research and development. In the six months ended June 30, 2019 and 2018, we recognized $0.9 million and $0.2 million, respectively, in stock-based compensation expense. A majority of the expense, $0.7 million and $0.2 million respectively, was recorded as selling and administrative expenses in the Consolidated Statement of Operations, with the remaining expenses incurred as cost of sales and research and development. As of June 30, 2019, unrecognized compensation cost related to non-vested stock options, deferred stock units and restricted stock units represents $8.4 million, which will be recognized over the remaining weighted average life of 4.2 years. Stock Option, Deferred Stock Unit and Restricted Stock Unit awards activity under the Omnibus Equity Incentive Plan for the six months ended June 30, 2019 was as follows: Stock options
| Number of Shares |  | Weighted- Average Exercise Price
Outstanding unvested as of December 31, 2018 | 968,720 |  |  | 15.68 |
Granted | 207,000 |  |  | 13.03 |
Vested | (175,410 | ) |  | 15.37 |
Forfeited | (52,622 | ) |  | 15.00 |
Outstanding unvested as of June 30, 2019 | 947,688 |  |  | 15.20 |
Deferred Stock Unit and Restricted Stock Unit awards
| Number of Shares |  | Weighted- Average Grant Date Fair Value
Outstanding unvested as of December 31, 2018 | 27,570 |  |  | 12.88 |
Granted | 240,564 |  |  | 12.90 |
Vested | (6,653 | ) |  | 13.42 |
Outstanding unvested as of June 30, 2019 | 261,481 |  |  | 12.95 |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration